Aspire Biopharma Holdings Inc. 宣布,其可转换A类优先股对应的普通股将进行转售,规模最高可达159,090,906股。
Aspire Biopharma Holdings Inc. 宣布,其可转换A类优先股对应的普通股将进行转售,规模最高可达159,090,906股。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.